ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,398Medicare Part D Prescriptions Filled, Including Refills

Rank: 106 out of 1383

$623K Total Retail Price of All Prescriptions

Rank: 229 out of 1383

573 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 573 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 573 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 12,805 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LEVOTHYROXINE SODIUM 662 540 1 4
HYDROCODONE-ACETAMINOPHEN 654 416 S3 2 1
METFORMIN HCL 558 378 3 8
OMEPRAZOLE 509 405 4 5
SIMVASTATIN 491 344 5 2
PRAVASTATIN SODIUM 463 339 6 14
LISINOPRIL 438 364 7 3
FUROSEMIDE 393 306 8 7
AMLODIPINE BESYLATE 386 332 9 6
HYDROCHLOROTHIAZIDE 334 294 10 10
METOPROLOL TARTRATE 330 277 11 9
TRAMADOL HCL 264 172 12 25
ATENOLOL 263 208 13 16
WARFARIN SODIUM 261 227 14 13
LOVASTATIN 259 236 15 22
GLIMEPIRIDE 211 165 16 31
GABAPENTIN 191 108 17 11
GLYBURIDE 187 155 R 18 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 179 153 19 27
POTASSIUM CHLORIDE 178 141 20 12
PREDNISONE 174 121 21 40
AZITHROMYCIN 174 142 21 41
RANITIDINE HCL 168 117 23 19
CLOPIDOGREL 160 130 24 28
CITALOPRAM HBR 158 90 25 15
ZOLPIDEM TARTRATE 157 114 26 17
BENAZEPRIL HCL 156 118 27 38
ATORVASTATIN CALCIUM 152 143 28 18
LOSARTAN POTASSIUM 138 113 29 23
SERTRALINE HCL 137 93 30 21
KLOR-CON 10 135 119 31 74
TAMSULOSIN HCL 134 133 32 30
PLAVIX 130 105 33 43
GEMFIBROZIL 130 89 33 90
DONEPEZIL HCL 122 114 35 35
CARVEDILOL 121 107 36 24
BENAZEPRIL-HYDROCHLOROTHIAZIDE 117 70 37 144
CRESTOR 117 73 37 34
DOXYCYCLINE HYCLATE 115 91 39 94
PANTOPRAZOLE SODIUM 114 105 40 32
MELOXICAM 114 76 40 20
POLYETHYLENE GLYCOL 3350 112 68 42 64
CIPROFLOXACIN HCL 111 104 43 54
TRIAMTERENE-HCTZ 109 108 44 48
ALLOPURINOL 106 105 45 33
PROAIR HFA 98 74 46 42
CLONIDINE HCL 95 79 47 44
AMITRIPTYLINE HCL 92 92 R 48 57
VERAPAMIL ER 89 84 49 84
DILTIAZEM ER 86 84 50 110
NABUMETONE 85 69 51 156
TRAZODONE HCL 84 48 52 36
ESTRADIOL 83 74 R 53 96
MECLIZINE HCL 82 65 54 113
DIGOXIN 81 57 55 59
NEXIUM 80 52 56 26
TIZANIDINE HCL 79 58 57 104
SPIRONOLACTONE 76 66 58 67
ALENDRONATE SODIUM 76 55 58 37
METOPROLOL SUCCINATE 75 65 60 29
AMOX TR-POTASSIUM CLAVULANATE 74 50 61 106
DILTIAZEM 24HR CD 72 57 62 95
JANUVIA 72 70 62 85
SPIRIVA 71 55 64 45
COMBIVENT 71 65 64 116
PAROXETINE HCL 70 59 66 55
BISOPROLOL-HYDROCHLOROTHIAZIDE 70 48 66 155
AMOXICILLIN 69 48 68 119
TRIAMCINOLONE ACETONIDE 66 45 69 159
DIOVAN 63 50 70 58
ETODOLAC 59 41 71 198
ROPINIROLE HCL 58 39 72 79
FOSINOPRIL SODIUM 56 48 73 204
NAMENDA 55 51 74 49
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 51 75 89
CARISOPRODOL 53 0 R 76 76
FLUOXETINE HCL 52 25 77 52
CEPHALEXIN 51 40 78 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.